Webinar: Monkeypox Emergence - POCTRN

Center news

null Webinar: Monkeypox Emergence

Webinar - Monkeypox: Emergence of a Global Public Health Threat

Monkeypox has emerged as a global public health threat. Our understanding of this disease is improving, however, many questions remain. This webinar will cover what is known about the epidemiology, pathogenesis, clinical features, diagnostics, and treatment of this disease. Questions yet to be answered will be explored.


Bruce Tromberg, PhD 
Director, National Institute of Biomedical Imaging and Bioengineering

Matthew M Hamill, M.B.Ch.B., Ph.D., M.P.H., M.Sc. 
Assistant Professor of Medicine
Division of Infectious Diseases at Johns Hopkins School of Medicine
Clinical Chief for STI at Baltimore City Health Department.

Yukari C. Manabe, MD, FIDSA, FRCP 
Professor of Medicine, MMI, International Health
Director, Johns Hopkins Center for Innovative Diagnostics for Infectious Diseases
Associate Director of Global Health Research and Innovation
Johns Hopkins Center for Global Health

When: September 27, 2022 2:30 PM ET

Watch the recording >

Download the slides >

RADx: Rapid Acceleration of Diagnostics

In response to the COVID-19 pandemic, the Rapid Acceleration of Diagnostics (RADx®) initiative was formed to accelerate the development, validation, and commercialization of innovative point-of-care and home-based tests, as well as improvements to clinical laboratory tests, that can directly detect SARS-CoV-2, the virus that causes COVID-19.


In the News 

Two New Over-the-Counter At-Home COVID-19 Tests Brought to U.S. Market Quickly by Biden-Harris Administration

New HHS actions add to Biden administration efforts to increase access to easy-to-use over-the-counter COVID-19 tests

NIH RADx initiative expands COVID-19 testing innovation for additional types of rapid tests

The need for new test verification and regulatory support for innovative diagnostics

NIH-funded screening study builds case for frequent COVID-19 antigen testing

RADx partnerships speed new COVID testing

One Year of RADx Tech Success

Publication reveals essential ingredients of the groundbreaking NIH RADx national diagnostics effort 

Innovative COVID-19 Testing RADx Tech Reports Unveiled in Special Issue of IEEE Open Journal of Engineering in Medicine and Biology

Luminostics Announces FDA Authorization and Production Scale-Up of US-Manufactured Smartphone-Based COVID-19 Rapid Test

RADx Expects COVID-19 Portfolio to Accelerate an Era of At-Home Infectious Disease Testing (Login Required)

VIC Foundry, Inc. Receives NIH RADx Funding for Development of an At-home Molecular Diagnostic Test for COVID-19

Ceres Nanosciences Opens Advanced Particle Manufacturing Plant in Northern Virginia to Expand Nanotrap® Particle Manufacturing Capacity for COVID-19 Testing

COVID-19 Testing: Three Breakthrough Solutions in the RADx Initiative

NIH Director: Collaboration Amid Chaos, and Biden’s First 100 Days - How Francis Collins sees the COVID response changing with the new administration

The National Strategy From the COVID-19 Response and Pandemic Preparedness

Winners of HHS Design-a-thon to Develop Innovative Digital Health Tools for COVID-19 At-Anywhere Diagnostic Tests Announced

The Need for More and Better Testing for COVID-19